GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » Other Current Payables

Raia Drogasil (Raia Drogasil) Other Current Payables : $20 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil Other Current Payables?

Raia Drogasil's Other Current Payables for the quarter that ended in Mar. 2024 was $20 Mil.

Raia Drogasil's quarterly Other Current Payables declined from Sep. 2023 ($48 Mil) to Dec. 2023 ($8 Mil) but then increased from Dec. 2023 ($8 Mil) to Mar. 2024 ($20 Mil).

Raia Drogasil's annual Other Current Payables increased from Dec. 2021 ($14 Mil) to Dec. 2022 ($14 Mil) but then declined from Dec. 2022 ($14 Mil) to Dec. 2023 ($8 Mil).


Raia Drogasil Other Current Payables Historical Data

The historical data trend for Raia Drogasil's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Other Current Payables Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.63 3.21 13.58 14.08 8.18

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.34 33.08 48.34 8.18 20.42

Raia Drogasil Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Raia Drogasil Other Current Payables Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (Raia Drogasil) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (Raia Drogasil) Headlines

From GuruFocus

Q3 2023 Raia Drogasil S/A Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2018 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024